Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Respirology. 2019 Apr 22;24(12):1204–1211. doi: 10.1111/resp.13546

Figure 2.

Figure 2.

Difference in ODI4% between AutoEPAP and manual EPAP in all subjects, and subjects grouped by etiology of respiratory failure. OHS and other binned together due to small sample size. ODI4% while using AutoEPAP was non-inferior to manual EPAP in all subjects. There were no significant differences in ODI4% across the subgroups of neuromuscular disease, COPD, and OHS and other combined.

Note: Three outliers not displayed where ODI 4% > 40